Our current understanding of the biological impact of endometrial cancer mtDNA genome mutations and their potential use as a biomarker
Endometrial cancer (EC) is a devastating and common disease affecting women’s health. The NCI Surveillance, Epidemiology, and End Results Program predicted that there would be >66,000 new cases in the United States and >13,000 deaths from EC in 2023, and EC is the sixth most common can...
主要な著者: | , , , , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Frontiers Media S.A.
2024-06-01
|
シリーズ: | Frontiers in Oncology |
主題: | |
オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1394699/full |